Your browser doesn't support javascript.
loading
Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.
Göke, Friederike; Franzen, Alina; Menon, Roopika; Goltz, Diane; Kirsten, Robert; Boehm, Diana; Vogel, Wenzel; Göke, Antonia; Scheble, Veit; Ellinger, Joerg; Gerigk, Ulrich; Fend, Falko; Wagner, Patrick; Schroeck, Andreas; Perner, Sven.
Afiliação
  • Göke F; Institute of Pathology, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany; Institute of Prostate Cancer Research, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Franzen A; Institute of Pathology, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany; Institute of Prostate Cancer Research, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Menon R; Institute of Pathology, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany; Institute of Prostate Cancer Research, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Goltz D; Institute of Pathology, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Kirsten R; Institute of Prostate Cancer Research, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Boehm D; Institute of Prostate Cancer Research, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Vogel W; Institute of Prostate Cancer Research, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Göke A; Institute of Prostate Cancer Research, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Scheble V; Department of Hematology and Oncology, University Hospital of Tuebingen, Tuebingen, Germany.
  • Ellinger J; Department of Urology, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Gerigk U; Department of Thorax Surgery, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Fend F; Institute of Pathology, University Hospital of Tuebingen, Tuebingen, Germany.
  • Wagner P; Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Schroeck A; Institute of Prostate Cancer Research, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany; Department of Head and Neck Surgery, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany.
  • Perner S; Institute of Pathology, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany; Institute of Prostate Cancer Research, Affiliated Malteser Hospital, University Hospital of Bonn, Bonn, Germany. Electronic address: sven.perner1972@gmail.com.
Chest ; 142(4): 1020-1026, 2012 Oct.
Article em En | MEDLINE | ID: mdl-22499828
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA de Neoplasias / Carcinoma Pulmonar de Células não Pequenas / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA de Neoplasias / Carcinoma Pulmonar de Células não Pequenas / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2012 Tipo de documento: Article